Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects

Citation
Dkje. Von Lubitz et al., Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects, EUR J PHARM, 367(2-3), 1999, pp. 157-163
Citations number
43
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
367
Issue
2-3
Year of publication
1999
Pages
157 - 163
Database
ISI
SICI code
0014-2999(19990219)367:2-3<157:CAOAAR>2.0.ZU;2-Q
Abstract
We have previously shown that chronic administration of the selective A, re ceptor agonist N-6-(3-iodobenzyl)-5'-N-methylcarboxoamidoadenosine (IB-MECA ) leads to a significant improvement of postocclusive cerebral blood flow, and protects against neuronal damage and mortality induced by severe forebr ain ischemia in gerbils. Using immunocytochemical methods we now show that chronic with IB-MECA results in a significant preservation of ischemia-sens itive microtubule associated protein 2 (MAP-2), enhancement of the expressi on of glial fibrillary acidic protein (GFAP), and a very intense depression of nitric oxide synthase in the brain of postischemic gerbils. These chang es demonstrate that the cerebroprotective actions of chronically administer ed IB-MECA involve both neurons and glial cells, and indicate the possibili ty of distinct mechanisms that are affected in the course of chronic admini stration of the drug. (C) 1999 Elsevier Science B.V. All rights reserved.